FORT LAUDERDALE, Fla., June 3, 2013 (GLOBE NEWSWIRE) -- MAKO Surgical Corp. (Nasdaq:MAKO), a medical device company that markets its RIO® Robotic Arm Interactive Orthopedic surgical platform, MAKOplasty® joint specific applications and proprietary RESTORIS® implants that together enable orthopedic surgeons to consistently, reproducibly and precisely treat patient specific osteoarthritic disease, today announced that Ian Dawson has been appointed to the position of Senior Vice President of Marketing, assuming responsibility for MAKO's commercial marketing activities, which were formerly overseen by Ivan Delevic, who is transitioning to the position of Senior Vice President of Corporate Development. Mr. Dawson and Mr. Delevic will report to Maurice R. Ferré, M.D., MAKO's President and Chief Executive Officer.
Mr. Dawson has over 25 years of experience in marketing, with the majority of such experience in the medical device field. From June 2008 through May 2013, Mr. Dawson served as Vice President of North America Marketing for Smith & Nephew Advanced Wound Management, a manufacturer and supplier of advanced wound dressings and devices, where he was responsible for managing the entire marketing function for North America. From May 2004 to June 2008, Mr. Dawson held various marketing leadership positions with Zimmer, Inc., a manufacturer and supplier of orthopedic implants and surgical products, including Senior Director of U.S. Knee Marketing, where he was responsible for directing all marketing programs and activities related to Zimmer's knee products. From July 2001 to April 2004, he served as the Vice President - Product Group Knee, for Centerpulse Orthopedics Ltd., a manufacturer and supplier of orthopedic implants. Mr. Dawson holds a B.S. in Applied Biology from Chelsea College, University of London and a Diploma in Management Studies from Exeter College of Plymouth Polytechnic.
"Based on his impressive background and experience in orthopedics, Ian will be a valuable addition to the MAKO team," said Dr. Ferré.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV